A	a	O	O	O	O
randomized	randomized	O	O	O	O
comparison	comparison	O	O	O	O
of	of	O	O	O	O
labetalol	labetalol	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
nitroprusside	nitroprusside	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
induced	induced	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
.	.	O	O	O	O

In	in	O	O	O	O
a	a	O	O	O	O
randomized	randomized	O	O	O	O
study	study	O	O	O	O
,	,	O	O	O	O
labetalol-induced	labetalol-induced	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
and	and	O	O	O	O
nitroprusside-induced	nitroprusside-induced	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
were	were	O	O	O	O
compared	compared	O	O	O	O
in	in	O	O	O	O
20	20	O	O	O	O
patients	patients	O	O	O	O
(	(	O	O	O	O
10	10	O	O	O	O
in	in	O	O	O	O
each	each	O	O	O	O
group	group	O	O	O	O
)	)	O	O	O	O
scheduled	scheduled	O	O	O	O
for	for	O	O	O	O
major	major	O	O	O	O
orthopedic	orthopedic	O	O	O	O
procedures	procedures	O	O	O	O
.	.	O	O	O	O

Each	each	O	O	O	O
patient	patient	O	O	O	O
was	was	O	O	O	O
subjected	subjected	O	O	O	O
to	to	O	O	O	O
an	an	O	O	O	O
identical	identical	O	O	O	O
anesthetic	anesthetic	O	O	O	O
protocol	protocol	O	O	O	O
and	and	O	O	O	O
similar	similar	O	O	O	O
drug-induced	drug-induced	O	O	O	O
reductions	reductions	O	O	OTHERS	I
in	in	O	O	OTHERS	I
mean	mean	O	O	OTHERS	I
arterial	arterial	O	O	OTHERS	I
blood	blood	O	O	OTHERS	I
pressure	pressure	O	O	OTHERS	I
(	(	O	O	O	O
BP	bp	O	O	O	O
)	)	O	O	O	O
(	(	O	O	O	O
50	50	O	O	O	O
to	to	O	O	O	O
55	55	O	O	O	O
mmHg	mmhg	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Nitroprusside	nitroprusside	CHEMICALS	O	OTHERS	I
infusion	infusion	O	O	O	O
was	was	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
a	a	O	O	O	O
significant	significant	O	O	O	O
(	(	O	O	O	O
p	p	O	O	OTHERS	I
less	less	O	O	O	O
than	than	O	O	O	O
0.05	0.05	O	O	O	O
)	)	O	O	O	O
increase	increase	O	O	OTHERS	I
in	in	O	O	OTHERS	I
heart	heart	O	O	OTHERS	I
rate	rate	O	O	OTHERS	I
and	and	O	O	OTHERS	I
cardiac	cardiac	O	O	OTHERS	I
output	output	O	O	OTHERS	I
;	;	O	O	O	O
rebound	rebound	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
was	was	O	O	O	O
observed	observed	O	O	O	O
in	in	O	O	O	O
three	three	O	O	O	O
patients	patients	O	O	O	O
after	after	O	O	O	O
discontinuation	discontinuation	O	O	O	O
of	of	O	O	O	O
nitroprusside	nitroprusside	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Labetalol	labetalol	CHEMICALS	O	OTHERS	I
administration	administration	O	O	O	O
was	was	O	O	O	O
not	not	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
any	any	O	O	O	O
of	of	O	O	O	O
these	these	O	O	O	O
findings	findings	O	O	O	O
.	.	O	O	O	O

Arterial	arterial	O	O	O	O
PO2	po2	O	O	OTHERS	I
decreased	decreased	O	O	O	O
in	in	O	O	O	O
both	both	O	O	O	O
groups	groups	O	O	O	O
.	.	O	O	O	O

It	it	O	O	O	O
was	was	O	O	O	O
concluded	concluded	O	O	O	O
that	that	O	O	O	O
labetalol	labetalol	CHEMICALS	O	OTHERS	I
offers	offers	O	O	O	O
advantages	advantages	O	O	O	O
over	over	O	O	O	O
nitroprusside	nitroprusside	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

